Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-225973
Filing Date
2012-05-10
Accepted
2012-05-10 17:24:12
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d330071d10q.htm 10-Q 603646
2 EXECUTIVE EMPLOYMENT AGREEMENT d330071dex101.htm EX-10.1 85253
3 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 d330071dex311.htm EX-31.1 6862
4 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 d330071dex312.htm EX-31.2 6926
5 CERTIFICATIONS OF THE PEO AND THE PFO PURSUANT TO SECTION 906 d330071dex321.htm EX-32.1 4375
  Complete submission text file 0001193125-12-225973.txt   2181471

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ngsx-20120331.xml EX-101.INS 244351
7 XBRL TAXONOMY EXTENSION SCHEMA ngsx-20120331.xsd EX-101.SCH 12898
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ngsx-20120331_cal.xml EX-101.CAL 37197
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ngsx-20120331_lab.xml EX-101.LAB 112953
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ngsx-20120331_pre.xml EX-101.PRE 68095
Mailing Address 2215 BRIDGEPOINTE PARKWAY SUITE 200 SAN MATEO CA 94404
Business Address 2215 BRIDGEPOINTE PARKWAY SUITE 200 SAN MATEO CA 94404 650-358-3300
NeurogesX Inc (Filer) CIK: 0001385830 (see all company filings)

EIN.: 943307935 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33438 | Film No.: 12831436
SIC: 2834 Pharmaceutical Preparations